Serous papillary adenocarcinoma of the endometrium. A unique entity with a grave prognosis. Case report and review of the literature.
A case of Papillary Serous Adenocarcinoma of the endometrium is described. This unique variant of endometrial carcinoma was described initially only 10 years ago. The tumor has distinct pathological characteristics and a very grave prognosis. The importance of identifying this unique tumor type is related to appropriate treatment as well as to correct statistical analysis of endometrial carcinoma.
Lavie
O
O
Department of Obstetrics & Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.
Beller
U
U
Neuman
M
M
Rosemann
E
E
Diamant
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003536:Cystadenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D004317:Doxorubicin / Q000627:therapeutic use; D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D008875:Middle Aged; D010052:Ovariectomy; D010984:Platinum / Q000627:therapeutic use; D011379:Prognosis
D010984:Platinum; D004317:Doxorubicin; D003520:Cyclophosphamide